Benchmark stock market indices started the day steadily on Thursday, with investors treading cautiously before Tata Consultancy Services (TCS) announced its quarterly earnings—the first significant result of the Q2 season. By 9:21 am, the S&P BSE Sensex had climbed 92.15 points to reach 81,865.81, and the NSE Nifty50 was up by 40 points at 25,086.15. The broader market indices also showed modest gains, signaling a predominantly positive but measured kick-off to the trading session.
Pharma and IT stocks took the lead in driving optimism early on, with Dr. Reddy’s Laboratories, Sun Pharma, HCLTech, Wipro, and Infosys emerging as the top gainers. This sector’s momentum reflects a blend of defensive purchasing and cautious optimism in anticipation of key earnings announcements.
Dr. VK Vijayakumar, Chief Investment Strategist at Geojit Financial Services, emphasized the significance of the results season’s commencement in providing insights into corporate performance. He highlighted the ongoing challenges faced by the IT sector, suggesting that while there has been some recovery, significant obstacles persist. Regarding banking stocks, he mentioned their stagnation due to subdued earnings expectations, citing pressure on Net Interest Margins (NIM) and increasing delinquencies in unsecured loan segments. He advised investors to look out for outperformers in the banking sector.
Vijayakumar predicted that Q2 earnings would likely be modest, with attention shifting towards real economy indicators like automobile and consumer electronics demand. Encouraging reports of strong demand for these goods are anticipated to translate into positive results from Q3 onwards. He also noted the resilience of digital platform companies, which have been rewarded by the market for their sustained growth potential.
The overall sentiment on Dalal Street is one of cautious optimism, with traders eagerly anticipating TCS to set the tone for the upcoming earnings season.